Cepheid Investors

Investors

 

Welcome to Cepheid Investor Relations

Cepheid (Nasdaq: CPHD), based in Sunnyvale, Calif., is an on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. The Company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Cepheid's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges.

Featured EventsMore >>
There are currently no events scheduled.
Financial NewsMore >>
01/28/10Cepheid Reports Fourth Quarter and Full Year 2009 Results
Test Menu Expansion Drives Full Year Clinical Business Growth of 28%SUNNYVALE, Calif., Jan 28, 2010 /PRNewswire via COMTEX/ -- Cepheid (Nasdaq: CPHD) today reported revenue for the fourth quarter of 2009 of $49.2 million. Net loss was $4.3 million, or $(0.07) per share, which compares to revenue of $37.8 million and a net loss of $6.0 million, or $(0.10) per share, in the fourth quarter of fiscal 2008. Excluding amortization of purchased intangible assets and stock compensation expenses, non-... 
01/14/10Cepheid Schedules 2009 Fourth Quarter and Full Year Financial Results Announcement and Webcast
SUNNYVALE, Calif., Jan 14, 2010 /PRNewswire via COMTEX/ -- Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2009 fourth quarter and full year ended December 31, 2009, on Thursday, January 28, 2010, after the close of the market. The company will host a management presentation at 2 p.m. Pacific Time on Thursday, January 28, 2010, to discuss the results. To access the live webcast, please visit Cepheid's website at www.cepheid.com/investors at least 15 minute... 
Quick Links
Q409 Results
Q409 Earnings Call
Q309 10Q
2008 10K 
2008 Annual Report
ASM Results
Investor Resources
Q409 Results & Supplementary Data

Q409 Fact Sheet


On-Demand Report